OVAT — Ovation Science Balance Sheet
0.000.00%
- CA$1.54m
- CA$1.81m
- CA$0.11m
Annual balance sheet for Ovation Science, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1.54 | 0.648 | 0.029 | 0.049 | 0.003 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.05 | 0.094 | 0.06 | 0.005 | 0.032 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 2.49 | 0.758 | 0.099 | 0.075 | 0.064 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.02 | 0.012 | 0.005 | 0.002 | 0 |
| Net Intangible Assets | |||||
| Total Assets | 3.25 | 0.77 | 0.105 | 0.077 | 0.064 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.143 | 0.064 | 0.17 | 0.711 | 1.15 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.143 | 0.064 | 0.188 | 0.729 | 1.15 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 3.11 | 0.706 | -0.083 | -0.652 | -1.09 |
| Total Liabilities & Shareholders' Equity | 3.25 | 0.77 | 0.105 | 0.077 | 0.064 |
| Total Common Shares Outstanding |